Pietroni, Paola3; Vasisht, Nishi3; Cook, Jonathan P3; Roberts, David M3; Lord, J Michael3; Hartmann-Petersen, Rasmus4; Roberts, Lynne M3; Spooner, Robert A3
1 Biomolecular Sciences, Department of Biology, Faculty of Science, Københavns Universitet2 University of Warwick3 University of Warwick4 Biomolecular Sciences, Department of Biology, Faculty of Science, Københavns Universitet
The plant cytotoxin ricin enters mammalian cells by receptor-mediated endocytosis, undergoing retrograde transport to the endoplasmic reticulum (ER) where its catalytic A chain (RTA) is reductively separated from the holotoxin to enter the cytosol and inactivate ribosomes. The currently accepted model is that the bulk of ER-dislocated RTA is degraded by proteasomes. We show here that the proteasome has a more complex role in ricin intoxication than previously recognised, that the previously reported increase in sensitivity of mammalian cells to ricin in the presence of proteasome inhibitors simply reflects toxicity of the inhibitors themselves, and that RTA is a very poor substrate for proteasomal degradation. Denatured RTA and casein compete for a binding site on the regulatory particle of the 26S proteasome, but their fates differ. Casein is degraded, but the mammalian 26S proteasome AAA-ATPase subunit RPT5 acts as a chaperone that prevents aggregation of denatured RTA and stimulates recovery of catalytic RTA activity in vitro. Furthermore, in vivo, the ATPase activity of Rpt5p is required for maximal toxicity of RTA dislocated from the Saccharomyces cerevisiae ER. Our results implicate RPT5/Rpt5p in the triage of substrates in which either activation (folding) or inactivation (degradation) pathways may be initiated.
Biochemical Journal, 2013, Vol 453, Issue 3, p. 435-445